INTRODUCTION
============

Laparoscopic techniques in general surgery began with appendectomy, introduced by Semm in 1980 \[[@b1-ac-2018-10-18]\], and then cholecystectomy, introduced by Mühe in 1985 \[[@b2-ac-2018-10-18]\]. Since then, laparoscopic instruments and endoscopes have gradually developed and various surgical procedures have been performed. Laparoscopic-assisted surgery in colon cancer was considered in the 1990s \[[@b3-ac-2018-10-18]\]. Initially, it was not used widely because of doubts of its oncologic safety and recurrence of trocar wounds. However, large-scale randomized trials confirmed that the oncologic safety of laparoscopic-assisted surgery is not inferior to that of conventional open surgery. These large-scale trials include the clinical outcomes of the surgical therapy study group and the MRC CLASICC (medical research council conventional versus laparoscopic-assisted surgery in colorectal cancer) trial. Laparoscopic-assisted surgery was accepted as a substitute procedure for conventional open surgery due to its advantages of shorter hospital stay and wound minimization \[[@b4-ac-2018-10-18]-[@b6-ac-2018-10-18]\].

The da Vinci robotic surgical system (Intuitive Surgical Inc., Sunnyvale, CA, USA) was recently developed, and several institutions have reported their results. Despite some advantages, the high cost of the procedure has remained a problem \[[@b7-ac-2018-10-18]-[@b10-ac-2018-10-18]\].

An endoscope system is essential in laparoscopic-assisted surgery, and most endoscopes are held by a human assistant. However, as operation time increases, assistants may experience fatigue and capture unstable images due to tremor. Endoscope holder systems were developed to solve these problems and capture precise images. Initially, these were passive endoscope holders that attach to an endoscope \[[@b11-ac-2018-10-18], [@b12-ac-2018-10-18]\]. Since then, active endoscope holder systems were developed. With the recent development of robotic active endoscope holder systems, surgeons can adjust the endoscope without removing their hands from the instruments \[[@b13-ac-2018-10-18], [@b14-ac-2018-10-18]\].

The Soloassist II system (AKTORmed, Barbing, Germany), a robotic active endoscope holder system, is a joystick-guided endoscope remote control system \[[@b15-ac-2018-10-18]\]. This study aimed to compare the short-term outcomes of laparoscopic-assisted colon cancer surgery in a Soloassist II-assisted (SA) and a human-assisted (HA) groups.

METHODS
=======

Study population
----------------

A total of 76 patients with colon cancer who underwent laparoscopic-assisted right hemicolectomy (RHC) and anterior resection (AR) performed by a single surgeon at Wonkwang University Hospital between January 2017 and May 2018 were recruited from the consecutively enrolled registry and retrospectively analyzed.

Because our institution has used the Soloassist II system since October 2017, patients were divided into a HA group and a SA group (n = 43 and n = 33, respectively). All patients were diagnosed with colon cancer through pathologic biopsy and underwent elective surgery performed by the same surgeon. There were no inclusion criteria for applying the Soloassist II system. Conversion between HA laparoscopic surgery and SA laparoscopic surgery did not occur. This study was approved by the Institutional Review Board of Wonkwang University Hospital (WKUH 2018-07-007), and informed consent was waived.

Soloassist II system
--------------------

The Soloassist II system is a robotic active endoscope holder that can be moved by a joystick. It consists of the main body unit, a power unit, a universal joint, an endoscope clamp, and a joystick. It can be attached to the side rail of a surgical bed, and the main body can be covered by a disposable drape. Other settings were comparable to those of conventional laparoscopic-assisted operations, except for the use of the Soloassist II system ([Fig. 1](#f1-ac-2018-10-18){ref-type="fig"}). The joystick, endoscope clamp, and universal joint can be reused after sterilization in an autoclave. The Soloassist II system requires adjustment after installation. After insertion of the endoscope trocar, the tip of the endoscope clamp is moved to the trocar site and adjusted by pressing a button on the main body. Then, a surgeon can move the endoscope 360° using the joystick ([Fig. 2](#f2-ac-2018-10-18){ref-type="fig"}). Two small buttons on the joystick move the endoscope forward and backward (zoom in and out). Moreover, the endoscope can be moved manually by holding down the button on the main body.

Surgical procedures
-------------------

All surgical procedures were performed using the same method, endoscope, surgical bed, patient position, participant positions, and instrument positions, except for the use of the Soloassist II system in one group. All procedures were performed using standard laparoscopic-assisted surgery via conventional multiport methods. In cases of RHC, the endoscope trocar was inserted into the supra-umbilical area, and two operator ports were placed in the suprapubic area and left lower quadrant (LLQ), respectively. One assistant port was located in the epigastric area. The specimen was extracted via midline mini-laparotomy above the umbilicus. An extracorporeal ileocolic anastomosis was performed with intraluminal staples (ILS). For AR, the endoscope trocar was located on the left of the umbilicus, and 2 operator ports were placed in the right upper quadrant and right lower quadrant, respectively. One assistant port was inserted into the LLQ area. The sigmoid colon was extracted through mini-laparotomy of the LLQ. Intracorporeal colo-colic anastomosis was performed with ILS inserted through the anus. The HA group included 1 operator and 2 assistants, whereas the SA group included 1 operator and 1 assistant. The operator was an experienced colorectal surgeon who had experience performing laparoscopic-assisted surgery, including robot-assisted surgery (\>400 cases). However, he was not experienced in using the Soloassist II system before this study.

Clinical data and study end points
----------------------------------

The primary end point of the study was comparison of early surgical outcomes. Operation time (minutes), postoperative length of hospital stay (LOHS, days), estimated intraoperative blood loss (mL), and complication events were assessed. Operation time was measured in minutes from skin incision to skin suture. LOHS was measured in days from surgery to discharge. Blood loss was assessed by suction volume and gauze weight. Complication events included only grade II or higher complications of the Clavien-Dindo classification that occurred until the postoperative hospital stay. The total number of harvested lymph nodes (LNs) was evaluated based on pathologic biopsy results. Open conversion, time to flatus (days), and time to soft diet (days) were also assessed.

Patient demographic data were also analyzed, including age, sex, body mass index, American Society of Anesthesiologists physical status classification, history of previous abdominal operation, operation method, and cancer stage.

Statistical analysis
--------------------

Comparisons of continuous variables between the 2 groups were made using independent t-test or Mann-Whitney U-test. The chi-square test and Fisher exact test were used to compare categorical variables. A 2-sided P-value \< 0.05 was considered significant. All statistical analyses were performed using IBM SPSS Statistics ver. 24.0 (IBM Co., Armonk, NY, USA).

RESULTS
=======

Of 76 patients (48 males and 28 females) included in the study, 43 underwent surgery with a human assistant and 33 had surgery with the Soloassist II system. The clinicopathologic characteristics of patients are shown in [Table 1](#t1-ac-2018-10-18){ref-type="table"}. No statistically significant or clinically significant differences were found between the 2 groups.

Short-term outcomes in the HA and SA groups
-------------------------------------------

[Table 2](#t2-ac-2018-10-18){ref-type="table"} presents short-term outcomes in the HA and SA groups. Despite the difference in how the endoscope was controlled, there was no difference in operation time between the 2 groups (HA: 220.23 ± 47.83 vs. SA: 218.03 ± 38.22, P = 0.829). The SA group had less blood loss than the HA group (HA: 79.77 ± 48.53 vs. SA: 68.79 ± 56.22); however, there was no statistical difference (P = 0.364). The total number of harvested LNs was not different between the HA and SA groups (20.42 ± 10.86 vs. 20.24 ± 8.21, P = 0.938). The open conversion did not occur in either group.

LOHS was not statistically different between groups (HA: 9.93 ± 3.07 vs. SA: 10.24 ± 3.19, P = 0.667). No significant differences were identified for time to flatus (HA: 2.07 ± 0.46 vs. SA: 2.24 ± 0.50, P = 0.122) or time to soft diet (HA: 5.84 ± 2.10 vs. 5.97 ± 2.14, P = 0.788). Postoperative complications occurred in 2 patients from the HA group due to minor anastomosis leakage. In the SA group, 1 patient had postoperative ileus and the other had pleural effusion. All complication events were class II of the Clavien-Dindo classification. There were no significant differences in complications between the 2 groups (P = 1.000).

Short-term outcomes according to the operation method
-----------------------------------------------------

The characteristics of subgroups were not statistically different, even though they were reclassified according to the operative method (data not shown). [Table 3](#t3-ac-2018-10-18){ref-type="table"} shows short-term outcomes of the subgroup according to the operative method. There was no difference in operation time between the HA and SA groups (RHC: 231.94 ± 61.55 vs. 221.94 ± 38.47, P = 0.650, AR: 211.80 ± 33.82 vs. 213.33 ± 38.71, P = 0.896). Subgroup comparisons of other parameters such as LOHS, blood loss, total harvested LNs, open conversion, time to flatus, and complication events revealed no statistical differences.

DISCUSSION
==========

Laparoscopic endoscopes and instruments have developed gradually over the past 30 years and have various applications in the surgical field. In colon cancer surgery, laparoscopic-assisted surgery is not inferior to conventional open surgery, as shown by large-scale randomized trials. Laparoscopic-assisted surgery provides some advantages, such as shorter hospital stay, surgical wound minimization, and reduced pain \[[@b5-ac-2018-10-18], [@b6-ac-2018-10-18], [@b16-ac-2018-10-18]\].

In laparoscopic-assisted surgery, it is important to acquire precise images to ensure safety. High-resolution endoscopes and even 3-dimensional technology have recently evolved to enable safer and more sophisticated procedures \[[@b17-ac-2018-10-18]\]. Despite these technological advances, a human assistant holds most endoscopes. As operation time increases, assistants may experience fatigue and capture unstable surgical images due to tremor. Endoscope holder systems were developed to solve these problems; these were initially designed as passive endoscope holders that attach to an endoscope. These holders had to be moved manually, and surgeons had to interrupt procedures to move the endoscopes \[[@b11-ac-2018-10-18], [@b12-ac-2018-10-18]\]. Therefore, active endoscope holders that can be moved using a surgeon's voice, infrared signals, or a joystick were developed so that surgeons do not need to remove their hands from instruments \[[@b18-ac-2018-10-18]\]. One of the first commercially available active endoscope holder systems was the AESOP (Computer Motion, Sunnyvale, CA, USA). Other active endoscope holders included the EndoAssist (Armstrong Healthcare Ltd., High Wycombe, UK), ViKY (EndoControl, Grenoble, France), FIPS Endoarm (Karlsruhe Research Centre, Karlsruhe, Germany), and Soloassist (AKTORmed, Barbing, Germany) \[[@b13-ac-2018-10-18]-[@b15-ac-2018-10-18], [@b19-ac-2018-10-18], [@b20-ac-2018-10-18]\].

Here, we compared the short-term outcomes of the HA and SA groups. Operation time and LOHS were not significantly different between the HA and SA groups ([Table 2](#t2-ac-2018-10-18){ref-type="table"}). In a previous study of cholecystectomy performed using the Soloassist, operation time was significantly shorter in the SA group than in the HA group (HA: 131.4 ± 57.8 vs. SA: 107.2 ± 47.5 minutes, P \< 0.01) \[[@b18-ac-2018-10-18]\]. In another study of Soloassist cholecystectomy, the operation time of the SA group was longer than that of the HA group (HA: median 90 vs. SA: median 104 minutes, P = 0.001) \[[@b15-ac-2018-10-18]\]. Similarly, other studies using various active endoscope holders showed a slight increase in operation time. However, most of these studies reported that the use of active endoscope holders decreased the need for a human assistant and increased surgeon satisfaction by providing a stable image. Other parameters that represented surgical outcomes, such as postoperative complications or LOHS, were similar \[[@b15-ac-2018-10-18], [@b18-ac-2018-10-18], [@b19-ac-2018-10-18], [@b21-ac-2018-10-18]\]. In our experience, there was one fewer assistant needed during surgery. The LOHS, blood loss, and complications of the SA group were not different from those of the HA group. The Soloassist II system is not inferior to conventional laparoscopic surgery in quantitative parameters that reflect short-term outcomes and can provide economic benefit by reducing the need for one assistant to control the endoscope. This system also requires little maintenance cost, except for sterile drapes \[[@b15-ac-2018-10-18], [@b18-ac-2018-10-18]\]. In addition, it can provide a solution for manpower shortage. In Korea, limited manpower in surgical departments has continued due to reduced application to surgical residency \[[@b22-ac-2018-10-18]\]. In these circumstances, the Soloassist II system is helpful. Other advantages of Soloassist II included ease of installation and removal. Moreover, it is attached to the side rail of a surgical bed and can easily be changed to a different position as needed. Of course, there were some drawbacks. Image rotation was automatic but not accurate. Trocars sometimes moved unexpectedly while zooming in and out if not tightly fixed. However, these problems were negligible during the operation.

In our experience, the Soloassist II system was easy to learn for inexperienced surgeons. It does not lead to prolonged operation time, increased LOHS, or additional complication events. These results are thought to be the same in all procedures except for those controlled by a joystick. In a previous study of cholecystectomy using the Soloassist, there was no defined learning curve or effect \[[@b15-ac-2018-10-18]\]. Similarly, rapid learning curves with active endoscope holders have been presented in other studies \[[@b13-ac-2018-10-18], [@b18-ac-2018-10-18]\].

We could not compare long-term oncologic outcomes due to the short follow-up period. Instead, the total number of harvested LNs, which is associated with the prognosis of patients with colon cancer, was compared \[[@b23-ac-2018-10-18]-[@b25-ac-2018-10-18]\], and there was no statistical difference between the two groups ([Table 2](#t2-ac-2018-10-18){ref-type="table"}). Because a single surgeon performed the procedures of both groups using the same method, the similar number of harvested LNs in both groups may be associated with the overall oncologic safety of the SA group. However, further studies are needed to evaluate the long-term oncologic outcomes.

This study had several limitations. Although patient characteristics were similar, there were hidden confounders and biases due to the retrospective nature of this study. Next, this study had a small sample size (n = 76). Lastly, the long-term outcomes of the 2 groups were not compared because the follow-up period was short. Nevertheless, this was one of the few studies that evaluated the feasibility of using the Soloassist II in laparoscopic-assisted colon cancer surgery.

In conclusion, the use of Soloassist II can decrease the need for a human assistant during surgery and is not inferior to human assistants in laparoscopic-assisted colon cancer surgery. Therefore, Soloassist II is considered a feasible instrument in laparoscopic-assisted colon cancer surgery with positive short-term outcomes. However, the long-term oncologic outcomes of laparoscopic-assisted colon cancer surgery using Soloassist II should be evaluated in further studies.

No potential conflict of interest relevant to this article was reported.

![Positioning of the Soloassist II system in laparoscopic-assisted right hemicolectomy (red arrow).](ac-2018-10-18f1){#f1-ac-2018-10-18}

![The surgeon can move the endoscope 360° using a joystick.](ac-2018-10-18f2){#f2-ac-2018-10-18}

###### 

Clinicopathologic characteristics of patients

  Variable                                                      HA (n = 43)     SA (n = 33)     P-value^[a](#tfn1-ac-2018-10-18){ref-type="table-fn"}^
  ------------------------------------------------------------- --------------- --------------- --------------------------------------------------------
  Sex                                                                                           0.301^[b](#tfn2-ac-2018-10-18){ref-type="table-fn"}^
   Male                                                         25 (58.1)       23 (69.7)       
   Female                                                       18 (41.9)       10 (30.3)       
  Age (yr)                                                      68.09 ± 10.16   71.21 ± 10.48   0.195
  Body mass index (kg/m^2^)                                     24.11 ± 3.02    24.24 ± 3.79    0.866
  ASA PS classification                                                                         0.487^[c](#tfn3-ac-2018-10-18){ref-type="table-fn"}^
   I                                                            2 (4.7)         1 (3.0)         
   II                                                           37 (86.0)       26 (78.8)       
   II                                                           4 (9.3)         6 (18.2)        
  Previous abdominal operation                                  7 (16.3)        3 (9.1)         0.499
  Operation method                                                                              0.272^[b](#tfn2-ac-2018-10-18){ref-type="table-fn"}^
   Right hemicolectomy                                          18 (41.9)       18 (54.5)       
   Anterior resection                                           25 (58.1)       15 (45.5)       
  Cancer stage^[d](#tfn4-ac-2018-10-18){ref-type="table-fn"}^                                   0.503^[c](#tfn3-ac-2018-10-18){ref-type="table-fn"}^
   0                                                            1 (2.3)         1 (3.0)         
   1                                                            11 (25.6)       11 (33.3)       
   2                                                            14 (32.6)       5 (15.2)        
   3                                                            15 (34.9)       15 (45.5)       
   4                                                            2 (4.7)         1 (3.0)         

Values are presented as number (%) or mean ± standard deviation.

HA, human-assisted group; SA, Soloassist II-assisted group; ASA PS, American Society of Anesthesiologists physical status classification.

Independent t-test.

Chi-square test.

Fisher exact test.

Stage according to American Joint Committee on Cancer cancer stage manual, 8th edition.

###### 

Short-term outcomes in human-assisted and Soloassist II-assisted groups

  Variable                      HA (n = 43)      SA (n = 33)      P-value^[a](#tfn5-ac-2018-10-18){ref-type="table-fn"}^
  ----------------------------- ---------------- ---------------- --------------------------------------------------------
  Operation time (min)          220.23 ± 47.83   218.03 ± 38.22   0.829
  LOHS (day)                    9.93 ± 3.07      10.24 ± 3.19     0.667
  Blood loss (mL)               79.77 ± 48.53    68.79 ± 56.22    0.364
  Total harvested lymph nodes   20.42 ± 10.86    20.24 ± 8.21     0.938
  Open conversion               0 (0)            0 (0)            
  Time to flatus (day)          2.07 ± 0.46      2.24 ± 0.50      0.122
  Time to soft diet (day)       5.84 ± 2.10      5.97 ± 2.14      0.788
  Complication events           2 (4.7)          2 (6.1)          1.000^[b](#tfn6-ac-2018-10-18){ref-type="table-fn"}^

Values are presented as mean ± standard deviation or number (%).

HA, human-assisted group; SA, Soloassist II-assisted group; LOHS, length of hospital stay.

Independent t-test.

Fisher exact test.

###### 

Short-term outcomes according to operation method

  Variable                      Right hemicolectomy   Anterior resection                                                                                            
  ----------------------------- --------------------- -------------------- ------------------------------------------------------ ---------------- ---------------- -------
  Operation time (min)          231.94 ± 61.55        221.94 ± 38.47       0.650                                                  211.80 ± 33.82   213.33 ± 38.71   0.896
  LOHS (day)                    10.72 ± 4.06          10.67 ± 4.03         0.584                                                  9.36 ± 2.02      9.73 ± 1.75      0.305
  Blood loss (mL)               101.67 ± 48.42        87.22 ± 66.05        0.181                                                  64.00 ± 42.92    46.67 ± 31.09    0.164
  Total harvested lymph nodes   24.33 ± 11.22         21.17 ± 8.36         0.323                                                  17.60 ± 9.87     19.13 ± 8.17     0.616
  Open conversion               0 (0)                 0 (0)                                                                       0 (0)            0 (0)            
  Time to flatus (day)          2.00 ± 0.49           2.33 ± 0.59          0.203                                                  2.12 ± 0.44      2.13 ± 0.35      0.978
  Time to soft diet (day)       6.06 ± 2.88           6.61 ± 2.66          0.161                                                  5.68 ± 1.35      5.20 ± 0.86      0.292
  Complication events           2 (11.1)              1 (5.6)              1.000^[b](#tfn8-ac-2018-10-18){ref-type="table-fn"}^   0 (0)            1 (6.7)          0.375

Values are presented as mean ± standard deviation or number (%).

HA, human-assisted group; SA, Soloassist II-assisted group; LOHS, length of hospital stay.

Independent t-test or Mann-Whitney U-test.

Fisher exact test.
